2-hydroxyisobutyryl-HIST1H3A (K122) Antibody

Shipped with Ice Packs
In Stock

Description

Target Characterization

The HIST1H3A gene (Gene ID: P68431) encodes a core histone H3.1 variant involved in nucleosome assembly. The K122 modification represents a recently identified acylation type linked to metabolic regulation and epigenetic signaling .

Key features of the modification site:

  • Structural role: Located in the globular core of histone H3, K122 participates in DNA-histone interactions.

  • Functional impact: 2-hydroxyisobutyrylation at this site correlates with transcriptional activation and chromatin relaxation .

Research Applications

Validated uses across experimental platforms:

ApplicationProtocol DetailsSupporting Evidence
Western BlotDetects ~17 kDa band in human cell lysatesConfirmed specificity in multiple lots
ELISAQuantitative analysis of modified histonesCompatible with sandwich assays
Epigenetic StudiesChromatin immunoprecipitation (ChIP) optimization ongoingCross-reactivity testing required

Technical Considerations

  • Specificity Controls: Recommended to use histone extracts from HeLa cells treated with histone deacylase inhibitors as positive controls .

  • Interference Risks: No observed cross-reactivity with acetylated or methylated H3K122 variants in validation studies .

  • Batch Consistency: ≥90% inter-batch reproducibility reported by manufacturers .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship your orders within 1-3 business days of receipt. Delivery times may vary depending on the purchase method and location. Please consult your local distributors for specific delivery timelines.
Synonyms
H3 histone family member E pseudogene antibody; H3 histone family; member A antibody; H3/A antibody; H31_HUMAN antibody; H3F3 antibody; H3FA antibody; Hist1h3a antibody; HIST1H3B antibody; HIST1H3C antibody; HIST1H3D antibody; HIST1H3E antibody; HIST1H3F antibody; HIST1H3G antibody; HIST1H3H antibody; HIST1H3I antibody; HIST1H3J antibody; HIST3H3 antibody; histone 1; H3a antibody; Histone cluster 1; H3a antibody; Histone H3 3 pseudogene antibody; Histone H3.1 antibody; Histone H3/a antibody; Histone H3/b antibody; Histone H3/c antibody; Histone H3/d antibody; Histone H3/f antibody; Histone H3/h antibody; Histone H3/i antibody; Histone H3/j antibody; Histone H3/k antibody; Histone H3/l antibody
Target Names
Uniprot No.

Target Background

Function
Histone H3 is a core component of the nucleosome, the fundamental unit of chromatin. Nucleosomes wrap and condense DNA, limiting its accessibility to cellular machinery that requires DNA as a template. As such, histones play a crucial role in regulating transcription, DNA repair, replication, and chromosomal stability. DNA accessibility is controlled through a complex interplay of post-translational modifications of histones, known as the histone code, and nucleosome remodeling.
Gene References Into Functions
  1. Studies suggest that epigenetic regulation in cancer involves the induction of E3 ubiquitin ligase NEDD4-dependent histone H3 ubiquitination. PMID: 28300060
  2. Elevated expression of H3K27me3 during a patient's disease course can be indicative of heterochronous tumors. PMID: 29482987
  3. JMJD5, a Jumonji C (JmjC) domain-containing protein, has been identified as a Cathepsin L-type protease that mediates histone H3 N-tail proteolytic cleavage under stress conditions leading to a DNA damage response. PMID: 28982940
  4. Research indicates that the Ki-67 antigen proliferative index has limitations, and phosphohistone H3 (PHH3) serves as an alternative marker for cell proliferation. PMID: 29040195
  5. Findings reveal that cytokine-induced histone 3 lysine 27 trimethylation stabilizes gene silencing in macrophages. PMID: 27653678
  6. In the early developing human brain, HIST1H3B constitutes the largest proportion of H3.1 transcripts among H3.1 isoforms. PMID: 27251074
  7. Among a series of 47 diffuse midline gliomas, the histone H3-K27M mutation was mutually exclusive with IDH1-R132H mutation and EGFR amplification, rarely co-occurred with BRAF-V600E mutation, and was commonly associated with p53 overexpression, ATRX loss, and monosomy 10. PMID: 26517431
  8. Data show that histone chaperone HIRA co-localizes with viral genomes, binds to incoming viral DNA, and deposits histone H3.3 onto these. PMID: 28981850
  9. Experiments demonstrate that PHF13 binds specifically to DNA and two types of histone H3 methyl tags (lysine 4-tri-methyl or lysine 4-di-methyl), functioning as a transcriptional co-regulator. PMID: 27223324
  10. Hemi-methylated CpGs DNA recognition activates UHRF1 ubiquitylation towards multiple lysines on the H3 tail adjacent to the UHRF1 histone-binding site. PMID: 27595565
  11. This study reports, for the first time, the MR imaging features of pediatric diffuse midline gliomas with histone H3 K27M mutation. PMID: 28183840
  12. Approximately 30% of pediatric high-grade gliomas (pedHGG), including GBM and DIPG, harbor a lysine 27 mutation (K27M) in histone 3.3 (H3.3), which is correlated with poor prognosis and has been shown to influence EZH2 function. PMID: 27135271
  13. H3F3A K27M mutation is not uncommon in adult cerebellar HGG. PMID: 28547652
  14. Lysyl oxidase-like 2 (LOXL2) is a histone modifier enzyme that removes trimethylated lysine 4 (K4) in histone H3 (H3K4me3) through an amino-oxidase reaction. PMID: 27735137
  15. Histone H3 lysine 9 (H3K9) acetylation was most prevalent when the Dbf4 transcription level was highest, whereas the H3K9me3 level was greatest during and immediately after replication. PMID: 27341472
  16. The SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing. PMID: 27614073
  17. Binding of the helical tail of histone 3 (H3) with PHD ('plant homeodomain') fingers of BAZ2A or BAZ2B (bromodomain adjacent to zinc finger domain 2A or 2B) involves molecular recognition of secondary structure motifs within the H3 tail, potentially representing an additional layer of regulation in epigenetic processes. PMID: 28341809
  18. Results demonstrate a novel mechanism by which Kdm4d regulates DNA replication by reducing the H3K9me3 level to facilitate the formation of the preinitiation complex. PMID: 27679476
  19. Histone H3 modifications are observed in leukocytes due to exposures to traffic-derived airborne particulate matter. PMID: 27918982
  20. Persistent histone H3 serine 10 or serine 28 phosphorylation plays a key role in chemical carcinogenesis by regulating the gene transcription of DNA damage response genes. PMID: 27996159
  21. hTERT promoter mutations are prevalent in medulloblastoma and are associated with older patients, a predisposition to recurrence, and tumors located in the right cerebellar hemisphere. Histone 3 mutations, however, are not typically found in medulloblastoma. PMID: 27694758
  22. AS1eRNA-driven DNA looping and activating histone modifications promote the expression of DHRS4-AS1 to economically control the DHRS4 gene cluster. PMID: 26864944
  23. Nuclear antigen Sp100C serves as a multifaceted sensor for histone H3 methylation and phosphorylation. PMID: 27129259
  24. Histone H3 threonine 118 phosphorylation via Aurora-A alters chromatin structure during specific phases of mitosis, facilitating timely condensin I and cohesin disassociation, which is essential for proper chromosome segregation. PMID: 26878753
  25. Hemi-methylated DNA induces an open conformation of UHRF1, facilitating its recognition of H3 histones. PMID: 27045799
  26. H3K9me3 plays a functional role in hypoxia, apoptosis, and the repression of APAK. PMID: 25961932
  27. These findings confirm that histone H3 is a true substrate for GzmA in vivo in Raji cells treated with staurosporin. PMID: 26032366
  28. Circulating H3 levels correlate with mortality in sepsis patients and inversely correlate with antithrombin levels and platelet counts. PMID: 26232351
  29. Double mutations on residues in the interface (L325A/D328A) decrease the histone H3 H3K4me2/3 demethylation activity of lysine (K)-specific demethylase 5B (KDM5B). PMID: 24952722
  30. MCM2 binding is not required for the incorporation of histone H3.1-H4 into chromatin but is essential for the stability of H3.1-H4. PMID: 26167883
  31. Histone H3 lysine methylation (H3K4me3) plays a crucial role in the maintenance of leukemia stem cells (LSCs). PMID: 26190263
  32. PIP5K1A modulates ribosomal RNA gene silencing through its interaction with histone H3 lysine 9 trimethylation and heterochromatin protein HP1-alpha. PMID: 26157143
  33. Lower-resolution mass spectrometry instruments can be used for analyzing histone post-translational modifications (PTMs). PMID: 25325711
  34. Inhibition of lysine-specific demethylase 1 activity prevents IL-1beta-induced histone H3 lysine 9 (H3K9) demethylation at the microsomal prostaglandin E synthase 1 (mPGES-1) promoter. PMID: 24886859
  35. De novo CENP-A assembly and kinetochore formation on human centromeric alphoid DNA arrays are regulated by a balance between histone H3K9 acetylation and methylation. PMID: 22473132

Show More

Hide All

Database Links

HGNC: 4766

OMIM: 137800

KEGG: hsa:8350

STRING: 9606.ENSP00000444823

UniGene: Hs.132854

Involvement In Disease
Glioma (GLM)
Protein Families
Histone H3 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is 2-hydroxyisobutyrylation of histone H3 and why is it significant in epigenetics research?

2-hydroxyisobutyrylation is a post-translational modification (PTM) of histones that plays a crucial role in epigenetic regulation. This modification occurs at specific lysine residues on histone proteins, including H3, and contributes to chromatin structure modulation and gene expression regulation. In the context of HIST1H3A, 2-hydroxyisobutyrylation at lysine positions (such as K18 or K122) represents an important epigenetic mark that researchers study to understand chromatin dynamics and transcriptional control mechanisms. This modification is part of the expanding "histone code" that determines genome function beyond the DNA sequence itself .

How do 2-hydroxyisobutyryl-HIST1H3A antibodies differ based on their target lysine residues (K18 vs. K122)?

The key difference between these antibodies is their target epitope specificity - they recognize 2-hydroxyisobutyryl modifications at distinct lysine positions on the histone H3.1 protein. The K18 antibody targets the modification at lysine 18, while the K122 antibody specifically recognizes the modification at lysine 122. These different lysine positions are located in distinct regions of the histone protein and likely serve different functional roles in chromatin regulation. The immunogens used to develop these antibodies contain peptide sequences surrounding the specifically modified lysine residue (K18 or K122) derived from human histone H3.1 . Researchers should select the appropriate antibody based on which specific modification site they need to investigate for their particular epigenetic research question.

What are the validated applications for 2-hydroxyisobutyryl-HIST1H3A antibodies, and which techniques yield optimal results?

2-hydroxyisobutyryl-HIST1H3A antibodies have been validated for multiple experimental applications:

ApplicationDescriptionRecommended Dilution
Western Blot (WB)Detection of protein expression levels1:100-1:1000
Immunocytochemistry (ICC)Cellular localization studies1:20-1:200
Immunofluorescence (IF)Visualization of target in fixed cells1:10-1:100
Chromatin Immunoprecipitation (ChIP)Analysis of protein-DNA interactionsAs specified in protocols
ELISAQuantification in solutionAs specified in protocols

For optimal results across these applications, researchers should perform careful antibody titration experiments to determine the ideal concentration for their specific sample type and experimental conditions. Western blotting typically yields excellent quantitative results for measuring global changes in histone modifications, while ChIP provides insights into genomic localization of the modifications .

What is the recommended protocol for monitoring 2-hydroxyisobutyryl-HIST1H3A modifications using flow cytometry?

Based on protocols established for histone modification analysis, a flow cytometry approach can be adapted for 2-hydroxyisobutyryl-HIST1H3A detection. The method involves:

  • Cell fixation with formaldehyde (typically 1-4%) for 10-15 minutes at room temperature

  • Permeabilization with ice-cold 90% methanol for 30 minutes

  • Blocking with PBS containing 0.5% BSA for 10 minutes

  • Incubation with primary 2-hydroxyisobutyryl-HIST1H3A antibody (1:50-1:200 dilution) for 1 hour

  • Washing with PBS containing 0.5% BSA (3×)

  • Incubation with fluorophore-conjugated secondary antibody for 30 minutes

  • Final washing and analysis by flow cytometry

Flow cytometry offers advantages for quantitative assessment of histone modifications in individual cells and can detect relative differences in modification levels with high sensitivity. Studies have shown that flow cytometry may provide superior quantitative results compared to western blotting for monitoring histone modifications in certain contexts .

How should samples be prepared and stored to preserve 2-hydroxyisobutyryl modifications for antibody detection?

To maintain the integrity of 2-hydroxyisobutyryl modifications for reliable antibody detection:

  • Sample Collection: Harvest cells or tissues rapidly and process immediately to prevent loss of modifications

  • Fixation: Use freshly prepared fixatives (4% paraformaldehyde or formaldehyde) when applicable

  • Protein Extraction: Include HDAC inhibitors (e.g., sodium butyrate) and protease inhibitors in lysis buffers

  • Storage Conditions:

    • Short-term (≤1 week): 4°C in appropriate buffer with preservatives

    • Long-term: -20°C or -80°C with 50% glycerol and protective agents (0.03% Proclin 300, 0.01M PBS, pH 7.4)

    • Avoid repeated freeze-thaw cycles

Research has shown that histone modifications can be reliably detected for up to 96 hours at various temperatures (4°C, 20°C, or 37°C), though stability decreases significantly after 96 hours at 37°C. For optimal results, analyze samples as soon as possible after collection, especially when quantitative comparisons are critical .

What are the critical considerations for lysine 122 modification preservation compared to other histone modification sites?

The preservation of lysine 122 modifications requires specific attention due to its location in the C-terminal region of histone H3, which may affect accessibility and stability differently than modifications at other sites like K18:

  • Extraction Methods: Use specialized histone extraction protocols that maintain the integrity of the histone C-terminal domain

  • Buffer Composition: Include deacetylase inhibitors specific to the enzymes that target K122 modifications

  • Sample Processing Time: Minimize processing time to prevent enzymatic removal of the modifications

  • Denaturing Conditions: Adjust denaturing conditions during western blotting procedures to ensure proper epitope exposure

  • Fixation Parameters: For immunofluorescence or ChIP applications, optimize fixation parameters specifically for K122 accessibility

These considerations are particularly important since the dynamics and stability of different histone modifications can vary based on their position within the histone protein and their functional roles in chromatin regulation .

How can 2-hydroxyisobutyryl-HIST1H3A antibodies be used to investigate the crosstalk between different histone modifications?

To investigate modification crosstalk using 2-hydroxyisobutyryl-HIST1H3A antibodies:

  • Sequential ChIP (Re-ChIP): Perform initial ChIP with 2-hydroxyisobutyryl-HIST1H3A antibody, followed by a second immunoprecipitation with antibodies against other modifications to identify co-occurrence patterns

  • Mass Spectrometry Integration: Combine antibody-based enrichment with mass spectrometry to identify and quantify multiple modifications on the same histone molecules

  • Proximity Ligation Assays: Detect spatial proximity between 2-hydroxyisobutyryl modifications and other histone marks within the same nucleosome

  • Combinatorial Immunofluorescence: Use multiplexed immunofluorescence with antibodies against different modifications to assess correlation patterns

  • Genome-wide ChIP-seq Analysis: Compare ChIP-seq profiles of 2-hydroxyisobutyryl-HIST1H3A with other histone marks to identify regions of overlap or mutual exclusivity

This integrated approach can reveal functional relationships between 2-hydroxyisobutyryl modifications and other epigenetic marks such as acetylation, methylation, or phosphorylation, providing insights into the complex regulatory mechanisms of the histone code .

What are the optimal strategies for multiplexing 2-hydroxyisobutyryl-HIST1H3A antibodies with other histone modification antibodies?

For effective multiplexing of 2-hydroxyisobutyryl-HIST1H3A antibodies with other histone modification antibodies:

  • Antibody Selection Criteria:

    • Choose antibodies raised in different host species to allow simultaneous detection

    • Verify absence of cross-reactivity between antibodies

    • Select antibodies with compatible working dilutions

  • Fluorophore Combination Strategies:

    • Use fluorophores with minimal spectral overlap

    • Apply appropriate compensation controls

    • Consider brightness hierarchy based on expected target abundance

  • Sequential Staining Protocols:

    • Block between sequential antibody applications

    • Consider mild stripping between applications if necessary

    • Optimize order of antibody application to minimize interference

  • Validation Approaches:

    • Perform single-antibody controls alongside multiplexed experiments

    • Include biological controls with known modification patterns

    • Validate results using alternative techniques

By carefully implementing these strategies, researchers can simultaneously analyze multiple histone modifications, enabling more comprehensive insights into the complex relationships within the epigenetic landscape .

What are common sources of non-specific binding with 2-hydroxyisobutyryl-HIST1H3A antibodies and how can they be mitigated?

Common sources of non-specific binding and their mitigation strategies include:

Source of Non-specificityMitigation Strategy
Cross-reactivity with similar modificationsUse highly purified antibodies validated for specificity
Insufficient blockingIncrease blocking time/concentration; use alternative blocking agents (BSA, normal serum, casein)
Excessive antibody concentrationTitrate antibody to optimal concentration; perform dilution series
Sample over-fixationOptimize fixation time and conditions; consider antigen retrieval
Protein aggregationImprove sample preparation; include detergents in washing buffers
Secondary antibody issuesInclude secondary-only controls; use cross-adsorbed secondary antibodies

Additionally, researchers should incorporate proper controls including:

  • No primary antibody control

  • Peptide competition assays with modified and unmodified peptides

  • Samples with known modification status (positive and negative controls)

These measures help ensure that the observed signals are specific to the 2-hydroxyisobutyryl modification at the intended lysine position (K122 or K18) .

How can researchers validate the specificity of 2-hydroxyisobutyryl-HIST1H3A antibodies for their particular experimental system?

To validate antibody specificity for 2-hydroxyisobutyryl-HIST1H3A in a specific experimental system:

  • Peptide Competition Assays:

    • Pre-incubate antibody with excess modified peptide (containing 2-hydroxyisobutyryl-K122 or K18)

    • Pre-incubate with unmodified peptide as control

    • Observe signal reduction only with the modified peptide

  • Modification Enzyme Manipulation:

    • Treat samples with HDAC inhibitors to increase modification levels

    • Compare signal intensity before and after treatment

    • Observe expected changes in signal intensity

  • Knockdown/Knockout Validation:

    • Deplete enzymes responsible for 2-hydroxyisobutyryl modification

    • Confirm reduction in signal using the antibody

  • Mass Spectrometry Correlation:

    • Analyze samples by both antibody-based detection and mass spectrometry

    • Confirm correlation between methods for modification abundance

  • Signal Localization Analysis:

    • Verify nuclear localization consistent with histone proteins

    • Confirm expected pattern distribution in chromatin

This comprehensive validation ensures that the antibody specifically recognizes the 2-hydroxyisobutyryl modification at the correct lysine residue in the particular experimental context .

How does detection of 2-hydroxyisobutyryl-HIST1H3A compare methodologically with detection of other histone H3 modifications?

Methodological comparison between 2-hydroxyisobutyryl-HIST1H3A and other histone H3 modifications:

Aspect2-hydroxyisobutyryl-HIST1H3AAcetylationMethylationPhosphorylation
Antibody SpecificitySite and modification-specificSite-specific, potential cross-reactivity between acetylation sitesSite and methylation state-specific (mono, di, tri)Site-specific, often phosphorylation-state dependent
Detection SensitivityComparable to acetylationHigh sensitivity, well-establishedVariant-dependentOften requires phosphatase inhibitors
Western Blot ConditionsStandard conditions with careful blockingStandard conditionsStandard conditionsPhosphatase inhibitors required
ChIP EfficiencyComparable to acetylationHigh efficiency, gold standardModification-state dependentOften lower efficiency
Flow Cytometry ApplicationEffective with proper permeabilizationWell-established methodEffective with proper controlsRequires special fixation
Stability During ProcessingModerately stableRelatively stableVery stableLess stable, easily lost

For optimal results across modification types, flow cytometry has proven particularly effective for quantitative analysis, offering superior sensitivity compared to western blotting in some contexts. Research has demonstrated that histone H3 modifications can be reliably detected across various storage conditions, though stability decreases significantly after prolonged storage at higher temperatures .

What are the emerging applications of 2-hydroxyisobutyryl-HIST1H3A antibodies in integrated multi-omics research approaches?

Emerging applications of 2-hydroxyisobutyryl-HIST1H3A antibodies in multi-omics research include:

  • Epigenome-Transcriptome Integration:

    • ChIP-seq with 2-hydroxyisobutyryl-HIST1H3A antibodies combined with RNA-seq

    • Correlation of 2-hydroxyisobutyryl modification patterns with gene expression profiles

    • Identification of regulatory elements marked by this modification

  • Chromatin Accessibility Correlation:

    • Integration of ChIP-seq data with ATAC-seq or DNase-seq

    • Analysis of 2-hydroxyisobutyryl modification enrichment at open chromatin regions

    • Characterization of chromatin state transitions associated with this modification

  • Protein Interaction Networks:

    • Identification of reader proteins that specifically recognize 2-hydroxyisobutyryl modifications

    • Characterization of writer and eraser enzymes regulating this modification

    • Mapping of interaction networks associated with modified histones

  • Single-Cell Applications:

    • Adaptation of antibodies for single-cell ChIP or CUT&Tag protocols

    • Integration with single-cell transcriptomics and proteomics

    • Characterization of cellular heterogeneity in modification patterns

These integrated approaches provide comprehensive insights into the functional role of 2-hydroxyisobutyryl modifications in chromatin biology and gene regulation, positioning this modification within the broader context of epigenetic regulation mechanisms .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.